c-myc Is a Downstream Target of the Smad Pathway
Open Access
- 1 January 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (1) , 854-861
- https://doi.org/10.1074/jbc.m104170200
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasisOncogene, 1999
- Role of p300, a transcriptional coactivator, in signalling of TGF‐βGenes to Cells, 1998
- A single missense mutant of Smad3 inhibits activation of both Smad2 and Smad3, and has a dominant negative effect on TGF‐β signalsFEBS Letters, 1998
- Myc activates telomeraseGenes & Development, 1998
- Identification of a Transforming Growth Factor-β1/Bone Morphogenetic Protein 4 (TGF-β1/BMP4) Response Element within the Mouse Tissue Transglutaminase Gene PromoterPublished by Elsevier ,1998
- Cell Cycle Regulation of E2F Site Occupation in VivoScience, 1996
- DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1Science, 1996
- Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite InstabilityScience, 1995
- TGF-β inhibition of endothelial cell proliferation: Alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expressionCell, 1987
- Suppression of the EGF-dependent induction of c-myc proto-oncogene expression by transforming growth factor β in a human breast carcinoma cell lineBiochemical and Biophysical Research Communications, 1987